{"id":"https://openalex.org/W4382393595","doi":"https://doi.org/10.1016/j.tips.2023.06.001","title":"Targeting galectin-3 in inflammatory and fibrotic diseases","display_name":"Targeting galectin-3 in inflammatory and fibrotic diseases","publication_year":2023,"publication_date":"2023-06-28","ids":{"openalex":"https://openalex.org/W4382393595","doi":"https://doi.org/10.1016/j.tips.2023.06.001","pmid":"https://pubmed.ncbi.nlm.nih.gov/37391294"},"language":"en","primary_location":{"id":"doi:10.1016/j.tips.2023.06.001","doi":"https://doi.org/10.1016/j.tips.2023.06.001","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.tips.2023.06.001","pdf_url":"http://www.cell.com/article/S0165614723001268/pdf","source":{"id":"https://openalex.org/S31167473","display_name":"Trends in Pharmacological Sciences","issn_l":"0165-6147","issn":["0165-6147","1873-3735"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Trends in Pharmacological Sciences","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"http://www.cell.com/article/S0165614723001268/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5092349981","display_name":"Selena Bouffette","orcid":"https://orcid.org/0000-0002-6793-1139","observed_orcids":["https://orcid.org/0000-0002-6793-1139"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I277688954","display_name":"Universit\u00e9 Paris-Saclay","ror":"https://ror.org/03xjwb503","country_code":"FR","type":"education","lineage":["https://openalex.org/I277688954"]},{"id":"https://openalex.org/I4210135308","display_name":"Servier (France)","ror":"https://ror.org/034e7c066","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210135308"]},{"id":"https://openalex.org/I4210166412","display_name":"Inflammation, Microbiome and Immunosurveillance","ror":"https://ror.org/05dy6wv04","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I277688954","https://openalex.org/I4210166412"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Selena Bouffette","raw_affiliation_strings":["Servier, Neurology and Immuno-inflammation Therapeutic Area, Servier R&D Center, Gif-sur-Yvette, France; Universit\u00e9 Paris-Saclay, Inserm, Inflammation Microbiome and Immunosurveillance, Orsay, France","Servier, Neurology and Immuno-inflammation Therapeutic Area, Servier R&D Center, Gif-sur-Yvette, France","Universit\u00e9 Paris-Saclay, Inserm, Inflammation Microbiome and Immunosurveillance, Orsay, France"],"raw_orcid":"https://orcid.org/0000-0002-6793-1139","affiliations":[{"raw_affiliation_string":"Servier, Neurology and Immuno-inflammation Therapeutic Area, Servier R&D Center, Gif-sur-Yvette, France; Universit\u00e9 Paris-Saclay, Inserm, Inflammation Microbiome and Immunosurveillance, Orsay, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I277688954","https://openalex.org/I4210135308","https://openalex.org/I4210166412"]},{"raw_affiliation_string":"Servier, Neurology and Immuno-inflammation Therapeutic Area, Servier R&D Center, Gif-sur-Yvette, France","institution_ids":["https://openalex.org/I4210135308"]},{"raw_affiliation_string":"Universit\u00e9 Paris-Saclay, Inserm, Inflammation Microbiome and Immunosurveillance, Orsay, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I277688954","https://openalex.org/I4210166412"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070944439","display_name":"Iuliana Botez","orcid":"https://orcid.org/0000-0002-3243-6322","observed_orcids":["https://orcid.org/0000-0002-3243-6322"]},"institutions":[{"id":"https://openalex.org/I4210135308","display_name":"Servier (France)","ror":"https://ror.org/034e7c066","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210135308"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Iuliana Botez","raw_affiliation_strings":["Servier, Drug Design Small Molecules Unit, Servier R&D Center, Gif-sur-Yvette, France"],"raw_orcid":"https://orcid.org/0000-0002-3243-6322","affiliations":[{"raw_affiliation_string":"Servier, Drug Design Small Molecules Unit, Servier R&D Center, Gif-sur-Yvette, France","institution_ids":["https://openalex.org/I4210135308"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034622975","display_name":"Fr\u00e9d\u00e9ric De Ceuninck","orcid":"https://orcid.org/0000-0003-4331-1637","observed_orcids":["https://orcid.org/0000-0003-4331-1637"]},"institutions":[{"id":"https://openalex.org/I4210135308","display_name":"Servier (France)","ror":"https://ror.org/034e7c066","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210135308"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Fr\u00e9d\u00e9ric De Ceuninck","raw_affiliation_strings":["Servier, Neurology and Immuno-inflammation Therapeutic Area, Servier R&D Center, Gif-sur-Yvette, France. Electronic address: frederic.deceuninck@servier.com","Servier, Neurology and Immuno-inflammation Therapeutic Area, Servier R&D Center, Gif-sur-Yvette, France"],"raw_orcid":"https://orcid.org/0000-0003-4331-1637","affiliations":[{"raw_affiliation_string":"Servier, Neurology and Immuno-inflammation Therapeutic Area, Servier R&D Center, Gif-sur-Yvette, France. Electronic address: frederic.deceuninck@servier.com","institution_ids":["https://openalex.org/I4210135308"]},{"raw_affiliation_string":"Servier, Neurology and Immuno-inflammation Therapeutic Area, Servier R&D Center, Gif-sur-Yvette, France","institution_ids":["https://openalex.org/I4210135308"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5034622975"],"corresponding_institution_ids":["https://openalex.org/I4210135308"],"apc_list":{"value":6830,"currency":"USD","value_usd":6830},"apc_paid":{"value":6830,"currency":"USD","value_usd":6830},"fwci":4.7121,"has_fulltext":false,"cited_by_count":170,"citation_normalized_percentile":{"value":0.97314815,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"44","issue":"8","first_page":"519","last_page":"531"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12387","display_name":"Galectins and Cancer Biology","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12387","display_name":"Galectins and Cancer Biology","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11142","display_name":"Advanced Glycation End Products research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1308","display_name":"Clinical Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14245","display_name":"Biomarkers in Disease Mechanisms","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/galectin-3","display_name":"galectin-3","score":1.0},{"id":"https://openalex.org/keywords/galectin-3-inhibitors","display_name":"galectin-3 inhibitors","score":0.9279999732971191},{"id":"https://openalex.org/keywords/fibrosis","display_name":"fibrosis","score":0.7160000205039978},{"id":"https://openalex.org/keywords/inflammation","display_name":"inflammation","score":0.972000002861023},{"id":"https://openalex.org/keywords/myocardial-fibrosis","display_name":"myocardial fibrosis","score":0.9639999866485596},{"id":"https://openalex.org/keywords/liver-fibrosis","display_name":"liver fibrosis","score":0.8370000123977661},{"id":"https://openalex.org/keywords/renal-fibrosis","display_name":"renal fibrosis","score":0.972000002861023},{"id":"https://openalex.org/keywords/pulmonary-fibrosis","display_name":"pulmonary fibrosis","score":0.9990000128746033},{"id":"https://openalex.org/keywords/covid-19","display_name":"COVID-19 pandemic","score":0.9359999895095825},{"id":"https://openalex.org/keywords/neuroinflammation","display_name":"neuroinflammation","score":0.8510000109672546},{"id":"https://openalex.org/keywords/respiratory-tract-infections","display_name":"respiratory infections","score":0.6539999842643738},{"id":"https://openalex.org/keywords/therapeutic-target","display_name":"therapeutic target","score":0.6489999890327454},{"id":"https://openalex.org/keywords/preclinical-models","display_name":"preclinical models","score":0.6460000276565552}],"concepts":[{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.47662436962127686},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.4764980673789978},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.45230937004089355},{"id":"https://openalex.org/C2776336362","wikidata":"https://www.wikidata.org/wiki/Q18028529","display_name":"Galectin-3","level":2,"score":0.42915087938308716},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.34274959564208984},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3335360884666443},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3311239778995514},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2208520472049713},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.12298914790153503}],"mesh":[{"descriptor_ui":"D000086382","descriptor_name":"COVID-19","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D005355","descriptor_name":"Fibrosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007249","descriptor_name":"Inflammation","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D037161","descriptor_name":"Galectins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D037502","descriptor_name":"Galectin 3","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.tips.2023.06.001","doi":"https://doi.org/10.1016/j.tips.2023.06.001","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.tips.2023.06.001","pdf_url":"http://www.cell.com/article/S0165614723001268/pdf","source":{"id":"https://openalex.org/S31167473","display_name":"Trends in Pharmacological Sciences","issn_l":"0165-6147","issn":["0165-6147","1873-3735"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Trends in Pharmacological Sciences","raw_type":"journal-article"},{"id":"pmid:37391294","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37391294","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Trends in pharmacological sciences","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.tips.2023.06.001","doi":"https://doi.org/10.1016/j.tips.2023.06.001","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.tips.2023.06.001","pdf_url":"http://www.cell.com/article/S0165614723001268/pdf","source":{"id":"https://openalex.org/S31167473","display_name":"Trends in Pharmacological Sciences","issn_l":"0165-6147","issn":["0165-6147","1873-3735"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Trends in Pharmacological Sciences","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4382393595.pdf"},"referenced_works_count":103,"referenced_works":["https://openalex.org/W1568121239","https://openalex.org/W1966077354","https://openalex.org/W1972974730","https://openalex.org/W1978655989","https://openalex.org/W1984439708","https://openalex.org/W2003254802","https://openalex.org/W2005087735","https://openalex.org/W2009388678","https://openalex.org/W2009640330","https://openalex.org/W2083397227","https://openalex.org/W2085040223","https://openalex.org/W2141016294","https://openalex.org/W2160977747","https://openalex.org/W2281484774","https://openalex.org/W2463944685","https://openalex.org/W2520071434","https://openalex.org/W2535633630","https://openalex.org/W2581780754","https://openalex.org/W2741016292","https://openalex.org/W2753188950","https://openalex.org/W2755093187","https://openalex.org/W2762801659","https://openalex.org/W2773733615","https://openalex.org/W2775139356","https://openalex.org/W2780261212","https://openalex.org/W2780753353","https://openalex.org/W2782647452","https://openalex.org/W2786703147","https://openalex.org/W2788992770","https://openalex.org/W2799629904","https://openalex.org/W2898359979","https://openalex.org/W2938377166","https://openalex.org/W2948133685","https://openalex.org/W2954469331","https://openalex.org/W2965616929","https://openalex.org/W2990486908","https://openalex.org/W2991974053","https://openalex.org/W2995177062","https://openalex.org/W3001124677","https://openalex.org/W3005910324","https://openalex.org/W3007057280","https://openalex.org/W3010158051","https://openalex.org/W3010539623","https://openalex.org/W3011767668","https://openalex.org/W3012245774","https://openalex.org/W3016529146","https://openalex.org/W3022665707","https://openalex.org/W3048494322","https://openalex.org/W3048566715","https://openalex.org/W3062126634","https://openalex.org/W3081687852","https://openalex.org/W3085166683","https://openalex.org/W3092601683","https://openalex.org/W3097068462","https://openalex.org/W3098974987","https://openalex.org/W3101707266","https://openalex.org/W3102870960","https://openalex.org/W3118222898","https://openalex.org/W3137164252","https://openalex.org/W3144926040","https://openalex.org/W3157330701","https://openalex.org/W3160215620","https://openalex.org/W3161795784","https://openalex.org/W3188095235","https://openalex.org/W3195465669","https://openalex.org/W3204158215","https://openalex.org/W3211777941","https://openalex.org/W3212440196","https://openalex.org/W3212830624","https://openalex.org/W4207066019","https://openalex.org/W4210747883","https://openalex.org/W4214931861","https://openalex.org/W4220825639","https://openalex.org/W4220903207","https://openalex.org/W4224072833","https://openalex.org/W4224251120","https://openalex.org/W4225541672","https://openalex.org/W4282939896","https://openalex.org/W4288177782","https://openalex.org/W4290565378","https://openalex.org/W4291803627","https://openalex.org/W4293063840","https://openalex.org/W4296248956","https://openalex.org/W4296759971","https://openalex.org/W4296982314","https://openalex.org/W4297238919","https://openalex.org/W4303520843","https://openalex.org/W4306932364","https://openalex.org/W4308039943","https://openalex.org/W4308364848","https://openalex.org/W4308451202","https://openalex.org/W4309269850","https://openalex.org/W4312113213","https://openalex.org/W4315701532","https://openalex.org/W4316500155","https://openalex.org/W4318067857","https://openalex.org/W4319263811","https://openalex.org/W4319754207","https://openalex.org/W4324028567","https://openalex.org/W4367626982","https://openalex.org/W6747023901","https://openalex.org/W6747504282","https://openalex.org/W6804190701"],"related_works":["https://openalex.org/W7212379990","https://openalex.org/W4386725502","https://openalex.org/W3007315664","https://openalex.org/W4367626982","https://openalex.org/W7166558783","https://openalex.org/W4414628885","https://openalex.org/W7164862525","https://openalex.org/W4220883757","https://openalex.org/W4297238919","https://openalex.org/W3034947721"],"abstract_inverted_index":{"Galectin":[0],"(Gal)-3":[1],"is":[2],"a":[3,8,36,46],"\u03b2-galactoside-binding":[4],"lectin":[5],"emerging":[6],"as":[7,35,78],"key":[9],"player":[10],"in":[11,40,84,97],"cardiac,":[12],"hepatic,":[13],"renal,":[14],"and":[15,18,25,72,74,105],"pulmonary":[16],"fibrosis":[17],"inflammation,":[19],"respiratory":[20],"infections":[21],"caused":[22],"by":[23,114],"COVID-19,":[24],"neuroinflammatory":[26],"disorders.":[27],"Here,":[28],"we":[29,55],"review":[30],"recent":[31,58],"information":[32],"highlighting":[33],"Gal-3":[34,66],"relevant":[37],"therapeutic":[38,111],"target":[39],"these":[41],"specific":[42],"disease":[43],"conditions.":[44],"While":[45],"causal":[47],"link":[48],"was":[49],"difficult":[50],"to":[51,63,108],"establish":[52],"until":[53],"now,":[54],"discuss":[56],"how":[57],"strategic":[59],"breakthroughs":[60],"allowed":[61],"us":[62],"identify":[64],"new-generation":[65],"inhibitors":[67],"with":[68,92],"improved":[69],"potency,":[70],"selectivity,":[71],"bioavailability,":[73],"report":[75],"their":[76],"usefulness":[77],"valuable":[79],"tools":[80],"for":[81],"proof-of-concept":[82],"studies":[83],"various":[85],"preclinical":[86],"models":[87],"of":[88],"the":[89,110],"aforementioned":[90],"diseases,":[91],"emphasis":[93],"on":[94],"those":[95],"actually":[96],"clinical":[98],"stages.":[99],"We":[100],"also":[101],"address":[102],"critical":[103],"views":[104],"suggestions":[106],"intended":[107],"expand":[109],"opportunities":[112],"provided":[113],"this":[115],"complex":[116],"target.":[117]},"counts_by_year":[{"year":2026,"cited_by_count":47},{"year":2025,"cited_by_count":77},{"year":2024,"cited_by_count":37},{"year":2023,"cited_by_count":9}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2023-06-29T00:00:00"}